Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.53 |
| ▸ | ECE1 | P42892 | 3/20 | 0.53 |
| ▸ | MMP1 | P03956 | 6/20 | 0.53 |
| ▸ | MMP2 | P08253 | 6/20 | 0.52 |
| ▸ | MMP8 | P22894 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 3/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.52 |
| ▸ | GRPR | P30550 | 1/20 | 0.51 |
| ▸ | IL1RN | P18510 | 2/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | EDNRA | P25101 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31296564 | 0.89 | EDNRA (0.60) | ERAP2ECE1MMP1MMP2MMP8 | |
| SCHEMBL31442415 | 0.85 | KISS1R (0.58) | ERAP2ECE1MMP1MMP2MMP8 | |
| SCHEMBL30120684 | 0.85 | GHSR (0.59) | ERAP2KISS1RIL1RNERAP1 | |
| SCHEMBL29658156 | 0.85 | OPRD1 (0.57) | KISS1R | |
| SCHEMBL29380319 | 0.84 | ERAP2 (0.64) | ERAP2ECE1MMP1MMP2MMP8 | |
| SCHEMBL31536185 | 0.84 | PRMT1 (0.55) | ERAP2ECE1KISS1RGRPRIL1RN | |
| SCHEMBL30538857 | 0.83 | ECE1 (0.57) | ERAP2ECE1MMP1MMP2MMP8 | |
| SCHEMBL30199174 | 0.83 | NPBWR1 (0.57) | ERAP2KISS1R | |
| SCHEMBL23417743 | 0.82 | OPRM1 (0.55) | ECE1MMP1MMP8MMP9 | |
| SCHEMBL31442375 | 0.82 | KISS1R (0.60) | ERAP2MMP1MMP2MMP8MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618828-B2 | Probe and method for detecting membrane-associated molecules in living cells | Lazar, Josef (CZ) | 2026-05-05 | — | — | US | disclosed |
| US-20230194503-A1 | Probe and Method for Detecting Membrane-Associated Molecules in Living Cells | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2023-06-22 | — | — | US | disclosed |
| EP-4184168-A1 | PROBE AND METHOD FOR DETECTING MEMBRANE-ASSOCIATED MOLECULES IN LIVING CELLS | Ustav organicke chemie a biochemie AV CR, v.v.i. (CZ) | 2023-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618828-B2 | Probe and method for detecting membrane-associated molecules in living cells | CD2BP2, APMAP, MBOAT1 | ERAP2 1236/4885ECE1 3907/4885MMP1 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.